Milan, Italy - April 20, 2015 - The Board of Directors of Sorin S.p.A. (MTA: Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular disease ("Sorin" or the "Company"), today formally approved the common cross-border merger terms relating to the cross border merger of Sorin into Sand HoldCo PLC ("HoldCo"), a wholly owned subsidiary of Sorin (the "Sorin Merger") and the relevant illustrative report.
click here to view the release
Common Cross Border Merger Terms Press Release April 20_FINAL_2.pdfdownload61.2 kB application/pdf
distributed by
|